About Neogen Corp. 
Neogen Corp.
Pharmaceuticals & Biotechnology
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.
Company Coordinates 
Company Details
620 Lesher Pl , LANSING MI : 48912-1509
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 104 Schemes (54.32%)
Foreign Institutions
Held by 135 Foreign Institutions (28.62%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. James Borel
Lead Independent Chairman of the Board
Mr. John Adent
President, Chief Executive Officer, Director
Dr. William Boehm
Independent Director
Dr. Ronald Green
Independent Director
Mr. G. Bruce Papesh
Independent Director
Mr. James Tobin
Independent Director
Ms. Darci Vetter
Independent Director
Revenue and Profits:
Net Sales:
225 Million
(Quarterly Results - May 2025)
Net Profit:
-612 Million
Pharmaceuticals & Biotechnology
USD 1,229 Million (Small Cap)
281.00
NA
0.00%
0.37
-0.16%
0.59






